{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:19:07Z","timestamp":1782901147653,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004030","name":"Jiangsu Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmcl.2026.130598","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:23:41Z","timestamp":1771950221000},"page":"130598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of C-9 boronated berberine derivatives with enhanced selectivity against breast cancer"],"prefix":"10.1016","volume":"136","author":[{"given":"Ying-Hao","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130598_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bmcl.2026.130598_bb0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","article-title":"Current knowledge and pharmacological profile of berberine: an update","volume":"761","author":"Kumar","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130598_bb0015","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1002\/ptr.7589","article-title":"Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: a comprehensive review","volume":"36","author":"Khoshandam","year":"2022","journal-title":"Phytother Res"},{"key":"10.1016\/j.bmcl.2026.130598_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237368","article-title":"Berberine as a potential anticancer agent: a comprehensive review","volume":"26","author":"Rauf","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2026.130598_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27144523","article-title":"Anticancer effects and mechanisms of berberine from medicinal herbs: an update review","volume":"27","author":"Xiong","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2026.130598_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107742","article-title":"Coptidis rhizoma and berberine as anti-cancer drugs: a 10-year updates and future perspectives","volume":"216","author":"Chen","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmcl.2026.130598_bb0035","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/molecules25061426","article-title":"Recent advances in Berberine inspired anticancer approaches: from drug combination to novel formulation technology and derivatization","volume":"25","author":"Habtemariam","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2026.130598_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01461","article-title":"Effects of berberine and its derivatives on cancer: a systems pharmacology review","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130598_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/aps.2016.125","article-title":"Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system","volume":"38","author":"Zou","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bmcl.2026.130598_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112593","article-title":"Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile","volume":"203","author":"Sobolova","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130598_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1039\/C4MD00264D","article-title":"Discovery of mitochondria-targeting berberine derivatives as the inhibitors of proliferation, invasion and migration against rat C6 and human U87 glioma cells","volume":"6","author":"Fu","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmcl.2026.130598_bb0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bmcl.2012.10.098","article-title":"Synthesis and anticancer activity of a novel series of 9-O-substituted berberine derivatives: a lipophilic substitute role","volume":"23","author":"Lo","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130598_bb0065","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.ejmech.2017.10.078","article-title":"Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1","volume":"143","author":"Wang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130598_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1248\/cpb.c20-00453","article-title":"Discovery of C-9 modified berberine derivatives as novel lipid-lowering agents","volume":"69","author":"Li","year":"2021","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bmcl.2026.130598_bb0075","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/jcb.27102","article-title":"Berberrubine and its analog, hydroxypropyl-berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol-lowering effects in human hepatoma HepG2 cells","volume":"120","author":"Cao","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bmcl.2026.130598_bb0080","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1016\/j.bmcl.2016.08.027","article-title":"Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) berberine derivatives","volume":"26","author":"Zhang","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130598_bb0085","doi-asserted-by":"crossref","first-page":"18865","DOI":"10.1038\/s41598-023-45116-0","article-title":"Structure\u2014yeast \u03b1-glucosidase inhibitory activity relationship of 9-O-berberrubine carboxylates","volume":"13","author":"Nguyen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2026.130598_bb0090","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ejmech.2011.01.016","article-title":"Synthesis of 9-substituted derivatives of berberine as anti-HIV agents","volume":"46","author":"Bodiwala","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130598_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2000-8536","article-title":"Antimicrobial activity of 9-O-acyl- and 9-O-benzoyl-substituted berberrubines","volume":"66","author":"Hong","year":"2000","journal-title":"Planta Med"},{"key":"10.1016\/j.bmcl.2026.130598_bb0100","doi-asserted-by":"crossref","first-page":"17611","DOI":"10.1039\/D1RA01339D","article-title":"Synthesis and antioxidant activities of berberine 9-O-benzoic acid derivatives","volume":"11","author":"Liu","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2026.130598_bb0105","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/fmc.13.38","article-title":"Boron chemicals in diagnosis and therapeutics","volume":"5","author":"Das","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2026.130598_bb0110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/tcr.201402100","article-title":"Boron-based drug design","volume":"15","author":"Ban","year":"2015","journal-title":"Chem Rec"},{"key":"10.1016\/j.bmcl.2026.130598_bb0115","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nchem.2814","article-title":"The versatility of boron in biological target engagement","volume":"9","author":"Diaz","year":"2017","journal-title":"Nat Chem"},{"key":"10.1016\/j.bmcl.2026.130598_bb0120","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1021\/acs.chemrev.3c00663","article-title":"The rise of boron-containing compounds: advancements in synthesis, medicinal chemistry, and emerging pharmacology","volume":"124","author":"Grams","year":"2024","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2026.130598_bb0125","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/acs.accounts.8b00154","article-title":"Versatile bioconjugation chemistries of ortho-boronyl aryl ketones and aldehydes","volume":"51","author":"Cambray","year":"2018","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmcl.2026.130598_bb0130","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1021\/acs.bioconjchem.9b00246","article-title":"Site-specific bioconjugation and multi-bioorthogonal labeling via rapid formation of a boron-nitrogen heterocycle","volume":"30","author":"Chio","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmcl.2026.130598_bb0135","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/acschembio.3c00139","article-title":"Development, characterization, and structural analysis of a genetically encoded red fluorescent peroxynitrite biosensor","volume":"18","author":"Pang","year":"2023","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2026.130598_bb0140","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s00044-024-03258-4","article-title":"Reversible in-situ assembly of PROTACs using iminoboronate conjugation","volume":"33","author":"Yang","year":"2024","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2026.130598_bb0145","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/cr941195u","article-title":"The chemistry of neutron capture therapy","volume":"98","author":"Soloway","year":"1998","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2026.130598_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.medp.2024.100041","article-title":"Boron neutron capture therapy of cancer: recent progress","volume":"1","author":"Zhao","year":"2024","journal-title":"Medicine Plus"},{"key":"10.1016\/j.bmcl.2026.130598_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.215795","article-title":"Novel promising boron agents for boron neutron capture therapy: current status and outlook on the future","volume":"511","author":"Xu","year":"2024","journal-title":"Coord Chem Rev"},{"key":"10.1016\/j.bmcl.2026.130598_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:55:00Z","timestamp":1777600500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2600065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"alternative-id":["S0960894X2600065X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130598","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of C-9 boronated berberine derivatives with enhanced selectivity against breast cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130598"}}